SBN
Click for more information
0.00% 0.0¢ sun biomedical limited

Cynata Therapeutics has orphan status for its stem cell...

  1. bigane
    332 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    13/12/13
    02:20
    Post #: 12695690
    Cynata Therapeutics has orphan status for its stem cell technology. From memory companies with orphan status get longer IP protection than a standerd patent. The regulatory pathway is still the same but drug trial sample sizes can be smaller.
    SBN Price at posting: 1.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.